Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07898124
Recruiting
TMV Vaccine Alone or With Toripalimab-tpzi for Recurrent Head and Neck Squamous Cell Carcinoma
Phase 1 · United States · 1 site
Registry update: 27 Oct 2026
NCT07783061
Recruiting
Reducing Cardiovascular Risks: The Role of Alcohol Use
Not applicable · United States · 1 site
Registry update: 6 Oct 2026
NCT07871201
Recruiting
Dynamic Arterial Elastance for Prediction of Vasopressor Requirement After Anesthesia Induction in Elective On-Pump CABG
Not applicable · 1 site
Registry update: 13 Oct 2026
NCT07858799
Recruiting
Early Feasibility Study of the Edwards APTURE Transcatheter Shunt System
Not applicable · Germany · 3 sites
Registry update: 5 Oct 2026
NCT07772960
Recruiting
Semaglutide Dose Effects on Metabolic and Stress Hormone, Craving and Alcohol Use Outcomes
Phase 1 · United States · 1 site
Registry update: 4 Nov 2026
NCT07853898
Recruiting
Effects of Pistachios on Postprandial Metabolic Responses in Adults With Overweight or Obesity
Not applicable · United States · 1 site
Registry update: 2 Oct 2026
NCT07816133
Recruiting
Study on the Ultrasound and Biological Characteristics of Atypical Endometriosis.
Not applicable · Italy · 1 site
Registry update: 11 Sept 2026
NCT07874490
Recruiting
Osimertinib and Cyclosporine A to Enhance Antitumor Efficacy in NSCLC
Phase 2 · United States · 1 site
Registry update: 15 Oct 2026
NCT07805369
Recruiting
A Phase 1 Study of DEM301 in Participants With Metastatic Colorectal Cancer
Phase 1 · Australia · 2 sites
Registry update: 28 Oct 2026
NCT07843940
Recruiting
A Study to Test Obrixtamig in Combination With Pumitamig in People With Advanced Small Cell Lung Cancer (Dareon®-Rosetta35)
Phase 1/2 · Australia, Belgium, China, Germany, Spain, France, Japan, Netherlands, Poland, United States · 26 sites
Registry update: 13 Oct 2026
NCT07696442
Recruiting
Sleep, Music, And Research Trial 2.0
Not applicable · Taiwan · 1 site
Registry update: 15 Oct 2026
2025-525030-57-00
Recruiting
A Phase III, Open-Label, Randomised, Multicentre, Global Study of Adjuvant Datopotamab Deruxtecan in Combination With Rilvegostomig in Participants With High-risk Muscle Invasive Urothelial Carcinoma.
Phase 3 · Germany, Spain, France, Italy, Poland · 44 sites
Registry update: 28 Sept 2026
NCT07847918
Recruiting
A Fully Remote Feasibility Trial of Phenylbutyrate for SLC6A1-Related Disorders
Phase 2 · United States · 1 site
Registry update: 29 Sept 2026
NCT07777367
Recruiting
Exercise Performance on Ambient Air vs. Low-Flow Liquid Oxygen Therapy in Chronic Lung Diseases
Not applicable · Switzerland · 1 site
Registry update: 9 Sept 2026
NCT07854886
Recruiting
Hypothalamic GLP-1 Response in Healthy Weight and Obesity
Not applicable · Denmark · 1 site
Registry update: 2 Nov 2026
NCT05880524
Recruiting
Reduction of SystemiC Inflammation After Ischemic Stroke by Intravenous DNase Administration (ReSCInD)
Phase 2 · Germany · 5 sites
Registry update: 11 Sept 2026
NCT07873450
Recruiting
SumMET: Study of [225Ac]Ac-FL-261 in Participants With Solid Tumors Overexpressing c-MET
Phase 1/2 · Australia, United States · 2 sites
Registry update: 29 Oct 2026
NCT06340620
Recruiting
EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope
Not applicable · United States · 1 site
Registry update: 20 Oct 2026
NCT07850791
Recruiting
A Prospective Study of Sacituzumab Tirumotecan Plus Pembrolizumab for Advanced Biliary Tract Cancer
Phase 2 · China · 1 site
Registry update: 5 Oct 2026
NCT07901751
Recruiting
Study to Evaluate the Efficacy of a Single Intravitreal Injection of RTx-015 in Participants With Retinitis Pigmentosa (PERCEPT)
Phase 2/3 · United States · 14 sites
Registry update: 28 Oct 2026

Ordered by registry start date. Freshness and sponsorship never change the order.